| Autor: |
Weisshaar E; Occupational Dermatology, Department of Dermatology, University of Heidelberg, Heidelberg, Germany., Bentz P; Occupational Dermatology, Department of Dermatology, University of Heidelberg, Heidelberg, Germany., Haufe E; Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Germany., Heinrich L; Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Germany., Apfelbacher C; Institute for Epidemiology and Preventive Medicine/Medical Sociology, University of Regensburg, Regensburg, Germany.; Institute of Social Medicine and Health Systems Research, Otto von Guericke University Magdeburg, Magdeburg, Germany., Heratizadeh A; Department of Dermatology, Allergy and Venerology, Hannover Medical School, Germany., Abraham S; Department of Dermatology, University Allergy Center, Medical Faculty Carl Gustav Carus, TU Dresden, Germany., Harder I; Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Germany., Kleinheinz A; Clinics for Dermatology, Elbe Klinikum Buxtehude, Germany.; Clinics and Outpatient Clinics for Dermatology and Allergy, LMU Munich, Germany., Wollenberg A; Clinics and Outpatient Clinics for Dermatology and Allergy, LMU Munich, Germany., Schäkel K; Department of Dermatology, University of Heidelberg, Germany., Wiemers F; Private Practice Dr. Franca Wiemers, Leipzig, Germany., Ertner K; Private Practice Dr. Konstantin Ertner, Nuernberg, Germany., Augustin M; Institute for Health Research in Dermatology, University Medical Center Hamburg, Germany., Wildberger J; Hautmedizin Bad Soden, Germany., von Kiedrowski R; CMSS - Company for Medical Study and Service Selters/Westerwald, Germany., Worm M; Clinics for Dermatology, Venerology and Allergy, Charité Berlin, Germany., Zink A; Department of Dermatology and Allergy, Technical University of Munich, Germany., Effendy I; Department of Dermatology and Allergology, Campus Bielefeld, University OWL, Germany., Asmussen A; Private Practice Dermatologie an der Lesum, Bremen., Pawlak M; Private Practice Dr. Anika Hünermund, Mario Pawlak, Heilbad Heiligenstadt, Germany., Sticherling M; Department of Dermatology, University of Erlangen, Germany., Hilgers M; Clinics for Dermatology and Allergy, University Hospital Aachen, Germany., Handrick C; Private Practice Dr. Christiane Handrick, Berlin, Germany., Quist S; Dermatology Clinic, Helix Medical Ecellence Center, Mainz, Germany., Schwarz B; Private Practice Dr. Beate Schwarz, Langenau, Germany., Bell M; Private Practice Dr. Magnus Bell, Andernach, Germany., Staubach-Renz P; Department of Dermatology and Allergy, University Medical Center Mainz, Germany., Hong-Weldemann SH; Private Practice Dr. med. Sung-Hei Hong-Weldemann, Freiburg, Germany., Homey B; Department of Dermatology, University of Duesseldorf, Germany., Bruecher J; Skin Outpatient Clinic, Magdeburg, Germany., Weidinger S; Center for Inflammatory Skin Diseases, Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Germany., Werfel T; Department of Dermatology, Allergy and Venerology, Hannover Medical School, Germany., Schmitt J; Center of Evidence-based Healthcare, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Germany. |
| Abstrakt: |
Competing Interests: Conflicts of interest: J.S. is coprincipal investigator of TREATgermany and reports institutional grants for investigator-initiated research from the German GBA, the BMG, BMBF, EU, Federal State of Saxony, Novartis, Sanofi, ALK and Pfizer. He participated in advisory board meetings as a paid consultant for Sanofi, Lilly and ALK. K.S. received honoraria as an investigator, speaker’s honoraria and grants, and has been an advisor for the following companies: AbbVie, Almirall-Hermal, Amgen, Biogen Idec, Boehringer-Ingelheim, Bristol Myers Squibb, Celgene, Eli-Lilly, Galderma, Janssen, LEO Pharma, Merck Serono, Morphosys, Novartis, Pfizer, Regeneron, Sanofi and UCB Pharma. L.H. is a research associate of TREATgermany, which is an academic, investigator-initiated clinical registry that is financially supported by AbbVie GmbH & Co. KG, Galderma S. A., LEO Pharma GmbH, Lilly Deutschland GmbH, Pfizer Inc. and Sanofi-Aventis Deutschland GmbH. S.A. has received lecture and/or consultancy fees from Novartis, LEO Pharma, Amgen, Lilly, Sanofi, Beiersdorf, Janssen, UCB and AbbVie. E.W. received consultancy fees from Sanofi/Genzyme and has participated in clinical trials for Galderma Ltd and TREVI Ltd. |
